Arctic Bioscience AS (DE:9TD) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Arctic Bioscience AS reports a significant increase in nutraceutical sales, with year-to-date revenues rising by 16.3% compared to last year, driven by strong growth in Asian and European markets. Despite challenges in meeting the primary endpoint of their HeROPA study due to high placebo rates, the company remains confident in its phospholipid-based technology and expects positive outcomes from the study’s continuation. The company is exploring funding opportunities to achieve a positive cash flow by early 2025.
For further insights into DE:9TD stock, check out TipRanks’ Stock Analysis page.
